Inhibition of the AAA ATPase p97/VCP with CB-5083, UPCDC-30245, or NMS-873 also significantly reduced viral infection, indicating that the ER-associated protein degradation (ERAD) pathway may serve as a potential target for the treatment of COVID-19. This evidence concerns the gene VCP and viral infectious disease.